Hodgkin's disease occurring in a patient with the Wiskott-Aldrich syndrome
โ Scribed by Phillip Periman; Thomas R. Callihan; Lawrence Lessin; Gerald W. King; Michael Blaese
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 449 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We report a child with Wiskott-Aldrich syndrome with severe, refractory, symptomatic thrombocytopenia who achieved an excellent response to combination therapy with vincristine 1.5 mg/m 2 ร 1 day, intravenous immunoglobulin 1 g/kg ร 3 days, and methylprednisolone 25 mg/kg ร 3 days (VIM) for 7 years
A case of Wiskott-Aldrich syndrome (WAS) suspected to have a deletion mutation in the WAS protein (WASP) gene had previously been reported (Ariga et al., 1997). Genomic polymerase chain reaction (PCR) suggested that exons 3-7 of the WASP gene were included in the deletion. Present Southern blot stud
Lymphocytes from patients with Wiskott-Aldrich syndrome (WAS) were studied 1) with prometaphase G banding to search for minor chromosome anomalies and 2) in mutagen stress assays to assess the extent of chromosome breakage under these conditions. One patient, a sporadic case of WAS, was found to hav